Objective. Clinical and magnetic resonance imaging (MRI ) data of 170 consecutive patients with inflammatory back pain (IBP) and/or oligoarthritis of the lower limbs were evaluated in a retrospective study. The aim was to determine the frequency of sacroiliitis and spondyloarthropathy (SpA) in this population, and to assess the significance of HLA B27 measurements for diagnosis in early disease.
PsA or arthritis associated with inflammatory bowel SpA (65.3%), 30 UOA (25.4%) and 11 had other definitive rheumatic diseases (9.3%). Of those, six were disease (AIBD) could be differentiated. $ Patients were grouped as probable SpA (pSpA) if the diagnosed as Lyme arthritis, two as sarcoidosis, two as rheumatoid arthritis and one as systemic lupus. ESSG criteria were formally not fulfilled, but there were other symptoms suggestive of SpA, such as
Of the 101 patients with IBP, 86 were diagnosed as SpA (85.1%) and seven as US (6.9%). Of the remaining uveitis, a possible but uncertain history of symptoms or a combination of the main symptoms. eight patients, one had infectious sacroiliitis due to streptococci (proven by biopsy) and another one $ Patients were categorized as undifferentiated sacroiliitis ( US ) if they had evidence of sacroiliitis obtained osteoarthritis diagnosed by X-ray and MRI. In the remaining six patients with initial symptoms suggestive by MRI, but no indication of SpA or other underlying diseases.
of IBP, non-inflammatory spinal diseases were diagnosed after physical and radiological examination $ A diagnosis of undifferentiated oligoarthritis ( UOA) was made if oligoarthritis of the lower limbs, but no (5.9%).
The results and observations of the remaining groups evidence of any other defined rheumatic disease, was present [8] .
are given in more detail in the subsequent paragraphs. Five antinuclear antibody-positive SpA patients who Another 22 patients with mechanical low back pain had concomitant Sjö gren's syndrome are described elsewho did not fulfil the clinical criteria for IBP [5] were where [9] . excluded.
The flexibility of the lumbar spine was measured Undifferentiated spondyloarthropathy according to Schober, a difference of <4 cm was consid-
The vast majority (n = 41) of the 46 uSpA patients had ered pathological. The thorax excursion was measured IBP (89%) and 30 had PALL (65%). The combination in the fourth intercostal space, a difference of ≤3 cm of IBP and PALL was most frequent (41%), followed was considered pathological in patients aged <40 yr by isolated IBP (26%) in uSpA; this was the other way with adjustment in elderly patients. Minor psoriatic round in AS. Isolated oligoarthritis without spinal manilesions were always searched for by careful history and festations was only observed in five uSpA patients physical examination. Colonoscopy for the exclusion of (11%). chronic inflammatory bowel disease was only performed
In only 2/14 uSpA patients with a short disease in symptomatic cases. HLA B27 was determined by the duration of <1 yr (14%) was isolated IBP found. This standard microlymphocytotoxicity test.
was less frequent than in uSpA with a disease duration Conventional X-rays of the sacroiliac joints were of >1 yr (n = 27), where 10 patients had isolated IBP carried out in all patients with IBP. Dynamic MRI of (37%). Limitation of lumbar spine mobility was found the sacroiliac joints was performed in patients with IBP in 41% and limited thorax excursion in 21% of the uSpA without definite changes in pelvic X-rays. The technique patients, respectively. of dynamic MRI performed after i.v. bolus injection Extra-articular symptoms were seen in 26 uSpA with the contrast agent gadolinium-diethylenetriamine patients (57%). These, either reported by the patient penta-acetic acid was recently described in detail [3] .
(only accepted if the location was suggestive and swelling The degree of enhancement was graded as described [3] was documented by a physician) or observed during in acute sacroiliitis, moderate or severe, and chronic clinical examination, were: enthesopathy 13 patients sacroiliitis, differentiated in four stages.
(29%), uveitis nine patients (20%) and dactylitis four patients (9%).
Results

Probable SpA
The characteristics of the eight patients who did not Of the 170 patients examined, 106 were classified as SpA and eight as pSpA, together 114 (67.1%). Thirty fulfil ESSG criteria, but who had symptoms suggestive of SpA, are given in Table 1 . Six of these patients had patients were categorized as UOA (17.6%) and seven as US (4.1%). The remaining 19 patients had or developed IBP, but no second SpA-defining clinical symptom or history. IBP and oligoarthritis, arthritis of the small other definitive inflammatory, infectious or degenerative diseases (11.2%). The characteristics and history of the hand joints, arthralgias or uveitis were observed. The remaining two had enthesopathy as the major complaint patients, including the HLA B27 results, are given in Table 1 aTime from first symptoms to the first visit.
same was true for seven US patients and one with AU were HLA B27 positive. In 93.3% of the cases, AU was present in addition to at least two other SpA bacterial sacroiliitis. HLA B27 was positive in 28/43 MRI-positive patients (65.1%), all these 28 had a diagfeatures (of the ESSG criteria). In only one case did a diagnosis of SpA became more probable due to the nosis of SpA.
The indications for MRI were normal or unclear presence of AU. findings on conventional pelvic X-rays in 32 cases.
Late-onset spondyloarthropathy Definite acute or chronic sacroiliitis detected by dynamic MRI was demonstrated in 21 of those 32 patients There were 13/106 patients who had a disease onset of >50 yr, here referred to as late-onset SpA (12.3%). (65.6%). Eleven of these 21 were clinically classified as uSpA, two as probable SpA, one as PsA (nine HLA Of these, 6/46 were diagnosed as uSpA (13%) and five fulfilled the modified New York criteria for AS. B27 positive) and seven were finally classified as US. An example is shown in Fig. 1 . The remaining 11
All 13 patients had IBP, nine had peripheral arthritis, eight oligoarthritis, one polyarthritis and three only patients had no sacroiliitis: three uSpA, one probable SpA (one HLA B27 positive), six with mechanical low arthralgias. back pain and one patient with osteoarthritis of the Undifferentiated oligoarthritis sacroiliac joints (all HLA B27 negative).
Thus, without knowledge of other clinical data, in a In 30 patients with isolated oligoarthritis, no definite rheumatic disease could be differentiated. Nine patients small population of 32 pre-selected patients with IBP, HLA B27 positively predicted a diagnosis of SpA in had monoarthritis (seven HLA B27 positive) and 21 oligoarthritis (two HLA B27 positive). The HLA 10/14 patients with MRI-proven sacroiliitis (71.4%), while HLA B27 negativity predicted a diagnosis of a B27-positive patients did not develop other signs of SpA on a 1 yr follow-up. disease other than SpA in 7/7 patients (100%).
Undifferentiated sacroiliitis
Discussion
Altogether, seven patients were classified as US, all women and HLA B27 negative. They had a relatively This study shows that SpA could be diagnosed in twothirds of 170 patients presenting with IBP and PALL. short disease duration of 2.3 yr. The erythrocyte sedimentation rate ( ESR) was slightly elevated in two Although one has to recognize that the described cohort presented to a tertiary referral centre specialized in patients and normal in the remainder. No indication of osteoarthritis, hyperparathyroidism, hyperuricaemia, inflammatory rather than degenerative rheumatic diseases, this finding supports recent data indicating a high tuberculosis or sarcoidosis was present. None of these patients developed another defined rheumatic disease on prevalence of SpA on a population basis [10] and also in general practitioner practices [11] . Among the SpA a mean follow-up of 3.6 yr (2.8-5.3).
All seven patients had moderate unilateral sacroiliitis subsets, uSpA, a subset that has not been widely recognized until recently [12] , was the most frequently diagdocumented by dynamic MRI according to the criteria recently proposed [3] . Enhancement of the contrast nosed classification group. This study, in accordance with a recent report from India on 'unclassifiable SpA', agent was <80% in all cases (mean 74 ± 23%) and the chronic changes <II in all seven patients.
backs the opinion that the main advantage of the ESSG criteria is the introduction of uSpA as a fifth SpA subset Anterior uveitis [13] . uSpA covers a spectrum of different overlapping SpA features, comprising patients with early onset of Altogether, there were 18 patients with past or present anterior uveitis (AU ) among the 114 patients with SpA not yet fully developed SpA [12] . Of interest, clinically, uSpA patients presented most frequently with both IBP and probable SpA (15.8%): nine uSpA, six AS, one PsA, one AIBD and one with pSpA. All patients with and PALL (40%), while isolated IBP occurred in only 25% in the first year, more frequently than isolated PALL than on IBP. This study also shows that a significant percentage of uSpA patients (13%), similar PALL (10%). Isolated IBP was observed more frequently in patients with longer disease duration (37%), to AS (15.6%), has a late onset of disease [14] , which is important for differential diagnosis in the elderly. possibly indicating that therapy has a better effect on However, the majority of uSpA and AS patients have may develop definite SpA in the further course of the disease [22] . an early onset. Importantly, one-third of uSpA patients
The latter is also relevant for the patient group may develop AS later in the disease [15] .
classified as UOA. In this group, there are two possible According to the ESSG classification criteria, a definindications of SpA: PALL itself and HLA B27, which ite diagnosis of SpA was made in 62% of the patients was present in 30%, which is significantly higher than of the clinical spectrum considered in this study. Since the HLA B27 prevalence of 9.3% in Berlin [10] . these criteria were shown to have a sensitivity of 85%, However, there are HLA B27-positive UOA patients which is even less in early disease [1] , we were not who never develop a clinical picture of SpA [22] , as was surprised to identify another eight patients who formally the case in the nine HLA B27-positive UOA patients in did not fulfil the ESSG criteria, but presented with this study; their clinical pattern did not change during symptoms suggestive of SpA. Four of these HLA a short 1 yr follow-up. B27-positive patients had evidence of sacroiliitis pro-
In conclusion, this study confirms the usefulness of vided by definite imaging. Only recently, we have shown the SpA concept in clinical practice [23] . USpA is a that HLA B27-positive Berlin blood donors with IBP frequent SpA subset which will have to be examined in were 10 times more likely to have sacroiliitis and SpA long-term follow-up studies. Other rheumatic diseases than HLA B27-negative donors [10] . These data are in with a similar clinical picture have to be differentiated, some accordance with earlier calculations performed for one of those being US. The probability of SpA is greatly AS by Khan and Khan [16 ] and others [17] . In concluincreased in patients with IBP and MRI-proven sacrosion, objective evidence of sacroiliitis by MRI in HLA iliitis if HLA B27 is positive. B27-positive patients with IBP is highly suggestive of SpA and, of importance for very early cases, this is also true if no other clinical signs of SpA are present. If our patients are representative, this will be of clinical signifi-
